SWIM
AUPH icon

Smallwood Wealth Investment Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Smallwood Wealth Investment Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.47K Hold
440
– – ﹤0.01% 350
2026
Q1 		$6.52K Hold
440
– – ﹤0.01% 352
2025
Q4 		$7.02K Hold
440
– – ﹤0.01% 335
2025
Q3 		$4.86K Hold
440
– – ﹤0.01% 353
2025
Q2 		$3.73K Hold
440
– – ﹤0.01% 365
2025
Q1 		$3.54K Buy
+440
New +$3.56K ﹤0.01% 357

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Smallwood Wealth Investment Management's AUPH Position: Q2 2026 in Review

Smallwood Wealth Investment Management held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 440 shares worth $7.47K. The position accounts for ﹤0.01% of the portfolio, ranked #350.

Smallwood Wealth Investment Management first reported a position in AUPH in Q1 2025 and has held it in 6 quarters since. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Smallwood Wealth Investment Management held 440 shares of Aurinia Pharmaceuticals worth $7.47K as of Q2 2026.
  • Smallwood Wealth Investment Management left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Smallwood Wealth Investment Management's portfolio in Q2 2026, its #350 holding.
  • Smallwood Wealth Investment Management first reported a position in Aurinia Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Smallwood Wealth Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.